Hemp Naturals Competitors

Hemp Naturals (OTCMKTS:HPMM) and Abacus Health Products (OTCMKTS:ABAHF) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, dividends, institutional ownership, earnings, valuation, risk and analyst recommendations.

Valuation & Earnings

This table compares Hemp Naturals and Abacus Health Products' top-line revenue, earnings per share (EPS) and valuation.

Profitability

This table compares Hemp Naturals and Abacus Health Products' net margins, return on equity and return on assets.

Analyst Recommendations

This is a summary of recent recommendations for Hemp Naturals and Abacus Health Products, as reported by MarketBeat.com.

Acreage (OTCMKTS:ACRGF) and Hemp Naturals (OTCMKTS:HPMM) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, dividends, profitability, valuation and risk.

Earnings and Valuation

This table compares Acreage and Hemp Naturals' revenue, earnings per share and valuation.

Profitability

This table compares Acreage and Hemp Naturals' net margins, return on equity and return on assets.

Analyst Recommendations

This is a summary of current ratings and price targets for Acreage and Hemp Naturals, as reported by MarketBeat.

Acreage currently has a consensus price target of $8.4333, indicating a potential upside of 204.45%. Given Acreage's higher possible upside, analysts clearly believe Acreage is more favorable than Hemp Naturals.

Summary

Acreage beats Hemp Naturals on 2 of the 2 factors compared between the two stocks.

Applied Biosciences (OTCMKTS:APPB) and Hemp Naturals (OTCMKTS:HPMM) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, dividends, profitability, valuation and risk.

Earnings and Valuation

This table compares Applied Biosciences and Hemp Naturals' revenue, earnings per share and valuation.

Profitability

This table compares Applied Biosciences and Hemp Naturals' net margins, return on equity and return on assets.

Analyst Recommendations

This is a summary of current ratings and price targets for Applied Biosciences and Hemp Naturals, as reported by MarketBeat.

Ayr Strategies (OTCMKTS:AYRSF) and Hemp Naturals (OTCMKTS:HPMM) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, dividends, profitability, valuation and risk.

Analyst Recommendations

This is a summary of current ratings and price targets for Ayr Strategies and Hemp Naturals, as reported by MarketBeat.

Ayr Strategies currently has a consensus price target of $34.8571, indicating a potential upside of 63.96%. Given Ayr Strategies' higher possible upside, analysts clearly believe Ayr Strategies is more favorable than Hemp Naturals.

Earnings and Valuation

This table compares Ayr Strategies and Hemp Naturals' revenue, earnings per share and valuation.

Profitability

This table compares Ayr Strategies and Hemp Naturals' net margins, return on equity and return on assets.

Summary

Ayr Strategies beats Hemp Naturals on 2 of the 2 factors compared between the two stocks.

Hemp Naturals (OTCMKTS:HPMM) and Can B (NASDAQ:CANB) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, dividends, valuation and analyst recommendations.

Analyst Ratings

This is a summary of current ratings and recommmendations for Hemp Naturals and Can B, as reported by MarketBeat.

Earnings & Valuation

This table compares Hemp Naturals and Can B's revenue, earnings per share (EPS) and valuation.

Profitability

This table compares Hemp Naturals and Can B's net margins, return on equity and return on assets.

Hemp Naturals (OTCMKTS:HPMM) and Cansortium (OTCMKTS:CNTMF) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, dividends, valuation and analyst recommendations.

Analyst Ratings

This is a summary of current ratings and recommmendations for Hemp Naturals and Cansortium, as reported by MarketBeat.

Cansortium has a consensus price target of $1.20, indicating a potential upside of 35.90%. Given Cansortium's higher possible upside, analysts clearly believe Cansortium is more favorable than Hemp Naturals.

Earnings & Valuation

This table compares Hemp Naturals and Cansortium's revenue, earnings per share (EPS) and valuation.

Profitability

This table compares Hemp Naturals and Cansortium's net margins, return on equity and return on assets.

Summary

Cansortium beats Hemp Naturals on 2 of the 2 factors compared between the two stocks.